• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to: "Decoding Tumor Biology of Colorectal Liver Metastases With Radiogenomics: A Novel Insight Into Surgical Approach Selection".

作者信息

Margonis Georgios Antonios, Andreatos Nikolaos, Wolfgang Christopher L, Weiss Matthew J

机构信息

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

出版信息

Ann Surg. 2019 Jan;269(1):e4-e5. doi: 10.1097/SLA.0000000000002846.

DOI:10.1097/SLA.0000000000002846
PMID:29864095
Abstract
摘要

相似文献

1
Reply to: "Decoding Tumor Biology of Colorectal Liver Metastases With Radiogenomics: A Novel Insight Into Surgical Approach Selection".
Ann Surg. 2019 Jan;269(1):e4-e5. doi: 10.1097/SLA.0000000000002846.
2
Decoding Tumor Biology of Colorectal Liver Metastases With Radiogenomics: A Novel Insight Into Surgical Approach Selection.利用放射基因组学解码结直肠癌肝转移的肿瘤生物学：手术方法选择的新见解
Ann Surg. 2019 Jan;269(1):e3-e4. doi: 10.1097/SLA.0000000000002843.
3
Comment on "Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases.".关于“解剖性切除改善KRAS突变型结直肠癌肝转移患者的无病生存期”的评论
Ann Surg. 2019 Apr;269(4):e47-e49. doi: 10.1097/SLA.0000000000002855.
4
Surgery: KRAS mutations and hepatic recurrence after treatment of colorectal liver metastases.手术：结直肠癌肝转移治疗后的KRAS突变与肝复发
Nat Rev Gastroenterol Hepatol. 2017 Nov;14(11):638-639. doi: 10.1038/nrgastro.2017.129. Epub 2017 Sep 20.
5
Is hepatectomy justified for patients with RAS mutant colorectal liver metastases? An analysis of 524 patients undergoing curative liver resection.对于患有RAS突变型结直肠癌肝转移的患者，肝切除术是否合理？对524例行根治性肝切除术的患者进行的分析。
Surgery. 2017 Feb;161(2):332-340. doi: 10.1016/j.surg.2016.07.032. Epub 2016 Aug 31.
6
Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases.RAS癌基因上的突变位置影响结直肠肝转移瘤切除术后的病理特征和生存情况。
Cancer. 2017 Feb 15;123(4):568-575. doi: 10.1002/cncr.30351. Epub 2016 Oct 13.
7
BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy.BRAF 突变是结直肠癌肝转移切除术的预后生物标志物。
J Surg Oncol. 2012 Aug 1;106(2):123-9. doi: 10.1002/jso.23063. Epub 2012 Feb 13.
8
Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases.接受新辅助化疗（包括使用贝伐单抗或西妥昔单抗）的结直肠癌肝转移患者在肝切除术后的组织学反应、肿瘤破坏模式及临床结局。
Eur J Surg Oncol. 2015 Jul;41(7):868-74. doi: 10.1016/j.ejso.2015.03.223. Epub 2015 Mar 24.
9
From multidisciplinary to personalized treatment of colorectal liver metastases: 4 reasons to consider RAS.从结直肠癌肝转移的多学科治疗到个性化治疗：考虑RAS的4个理由
Cancer. 2013 Dec 1;119(23):4083-5. doi: 10.1002/cncr.28348. Epub 2013 Sep 19.
10
[KRAS mutations and survival after resection of colorectal liver metastases].[KRAS突变与结直肠癌肝转移切除术后的生存情况]
Chirurg. 2015 Nov;86(11):1071. doi: 10.1007/s00104-015-0092-y.